- Business
- Data Horizon Co., Ltd. (3628.T) provides medical information services and data health support primarily to insurers in Japan. The company develops and offers software utilizing proprietary medical databases and patented systems to analyze receipt and medical checkup data; these services include data health PDCA planning, healthcare business support, medical expense optimization, health promotion notifications, generic drug receipt checks, and new polypharmacy management services. Headquartered in Hiroshima, Japan, and founded in 1982, Data Horizon operates exclusively within the Japanese market, focusing on the medical-related information segment with approximately 374 employees.
In October 2022, the company completed the acquisition of a 95% stake in DeSC Health Care Co., Ltd. from DeNA Co., Ltd. for 3.4 billion yen, enhancing its data healthcare capabilities through integration with DeSC's services such as the kencom health app and expanded insured databases. This followed a prior business alliance with DeSC established in April 2020, strengthening joint data utilization for health promotion and medical cost rationalization. More recently, on September 30, 2025, Data Horizon raised its fiscal year ending March 2026 net profit forecast by 63% to 6.2 billion yen, marking an upward revision to record-high profitability. The company also discontinued its shareholder newsletter in October 2025 to streamline IR communications and prioritize environmental considerations.